Over the last 40 years, powerful new medicines and sprawling public health programs have turned a deadly HIV outbreak into a manageable epidemic authorities could imagine one day coming to a close.
The Trump administration’s cuts to staff at the Centers for Disease Control and Prevention and to clinical trials now threaten to unwind that progress, affected CDC researchers and outside HIV experts warn.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.